	Synthetic and conventional magnetic resonance imaging for knee assessment in children with leukemia: a comparative study. Quant Imaging Med Surg Jin W, Zhang H, Liao Y, Xiong S, Lei X, Guo X, Yang Z, Zhang R, Liang H, Guo Y, Wu Q, Ye L, Zheng J, Xu R. PMID: 42273147 [PubMed]
	Feasibility and Effectiveness of CALGB 10403 Protocol in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: A Study at Seyed Al-Shohada Hospital, Isfahan, Iran. Int J Hematol Oncol Stem Cell Res Oghab P, Erfan A, Poorpoone M, Peikar MS. PMID: 42272603 [PubMed]
	Bone Marrow Metastasis of Embryonal Rhabdomyosarcoma in an Adult, Confounding as Acute Leukemia: A Diagnostic Challenge. Int J Hematol Oncol Stem Cell Res Singh S, Porwal J, Kumar K, Singh N, Nath UK. PMID: 42272602 [PubMed]
	Prognostic significance of therapy-induced senescence and SASP dynamics in acute myeloid leukemia: a retrospective cohort study. BMC Cancer Ma B, Zhang L. PMID: 42271269 [PubMed - as supplied by publisher]
	Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report. Leukemia Flerlage JE, Palese M, Birz S, Campo E, de Jong D, Eichenauer DA, Hartmann S, Hoppe RT, Jaffe ES, Natkunam Y, Quintanilla-Martinez L, Martins W, Binkley MS. PMID: 42271037 [PubMed - as supplied by publisher]
	Toxicity and efficacy of four carmustine-substituted conditioning regimens followed by autologous stem cell transplantation in lymphoma: a real-world comparative study. Ann Hematol Pang Y, Du X, Lu W, Shi J. PMID: 42270870 [PubMed - as supplied by publisher]
	Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations. Hematol Oncol Clin North Am Belsky JA, Shoag J, Harker-Murray PD, Kahn JM. PMID: 42270197 [PubMed - in process]
	Updates in Childhood Acute Lymphoblastic Leukemia. Hematol Oncol Clin North Am Zarnegar-Lumley S, McNeer JL. PMID: 42270196 [PubMed - in process]
	Risk of lymphoma associated with biologics and immunosuppressants in inflammatory bowel disease patients: a nationwide nested case-control study. Clin Gastroenterol Hepatol Meyer A, Weill A, Carbonnel F, Dray-Spira R. PMID: 42269996 [PubMed - as supplied by publisher]
	Microcosting of Childhood Hodgkin Lymphoma Treatment Across Resource Levels Using the Adapted Resource and Implementation Application Guidelines in the US. JCO Glob Oncol Aliabadi S, Kumar P, Lucas JT Jr, Norton M, Pauley JL, Sauer HE, Martinez JM, Yasui Y, Bhakta N, Bolous NS. PMID: 42269132 [PubMed - in process]
	Brentuximab Vedotin after AlloSCT for Relapsed/Refractory Hodgkin Lymphoma: GHSG BV-ALLO Phase II Trial. Blood Adv Scheid C, Jablonski J, Kerkhoff A, Stelljes M, Trautmann-Grill K, Bornhäuser M, Tischer J, von Bergwelt-Baildon M, Janson D, Ayuk FA, Kröger N, Holtick U, Richardson T, von Tresckow B, Fuchs M, Borchmann P, Bröckelmann PJ. PMID: 42269084 [PubMed - as supplied by publisher]
	Peripheral blood mRNA expression of IL37, IL1F10, and C17orf99 genes is altered in patients with B-acute lymphoblastic leukemia: a case-control study. Mol Biol Rep Kadhim NT, Abed RM. PMID: 42268443 [PubMed - in process]
	KIT and FLT3-ITD mutations do not predict outcomes in pediatric core-binding factor acute myeloid leukemia: findings from the C-HUANAN-AML-15 multicenter cohort study. Ann Hematol Zheng Y, Yu L, Le S, Li N, Feng X, Li C, Zheng M, Mai H, Jiang H, He X, Wen H, Xu H, Chen C, Yang L. PMID: 42268406 [PubMed - as supplied by publisher]
	The context-dependent role of the dsRNA response in linking A-to-I editing and ADAR to normal hematopoiesis and leukemia. Front Cell Dev Biol Li X, Xu J, Yu J. PMID: 42267183 [PubMed]
	Establishment and validation of a 28-day clinical outcome prediction model for acute promyelocytic leukemia based on an early platelet-coagulation factor combined transfusion strategy. Am J Cancer Res Zheng S, Zheng X, Li Z. PMID: 42266758 [PubMed]
	A study comparing the efficacy of R-CHOP and R-DA-EPOCH regimens in young, high-risk treatment-naÃ¯ve diffuse large B-cell lymphoma patients: a multicenter retrospective analysis. Am J Cancer Res Lan H, Ding Y, Liu M. PMID: 42266738 [PubMed]
	Predicting isocitrate dehydrogenase mutation status in acute myeloid leukemia from gene expression profiles by machine learning. NAR Genom Bioinform Jung I, Vitte AL, Chuffart F, Chevalier S, Mossuz P, Khochbin S, Bourova-Flin E. PMID: 42266574 [PubMed - in process]
	Beyond Chemoimmunotherapy: Emerging Cellular and Targeted Therapies in Transformed Follicular Lymphoma: A Scoping Review. Cancer Control Al-Mashdali AF, Ghasoub R, Hwafdeh S, Yassin MA. PMID: 42265975 [PubMed - in process]
	CSF ctDNA Molecular Clearance as a Prognostic Biomarker for Orelabrutinib-Treated Primary Central Nervous System Lymphoma: Insights From Comparison With PET-CT. Am J Hematol Sheng L, Hu H, Lai Y, Wang S, Wang D, Tang S, Xu K, Sun Y, Zhang P, Lai B, Hu L, Chen L, Pan Y, Nie S, Gao X, Fan L, Ouyang G. PMID: 42265756 [PubMed - as supplied by publisher]
	Upregulation of NFS1 and downregulation of GSDMD as prognostic biomarkers in acute myeloid leukemia: implications for diagnosis and therapeutic strategies. BMC Cancer Radwan SM, Mostafa D, Radwan RA, Elghobary HA, Elghamry WR, Kamal AM. PMID: 42265630 [PubMed - in process]

Articles 1 - 20 / 168188

Page 1 of 8410



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy